Authors: Isaac, M Slassi, A O'Brien, A Edwards, L MacLean, N Bueschkens, D Lee, DKH McCallum, K De Lannoy, I Demchyshyn, L Kamboj, R

Citation: M. Isaac et al., Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: Potential therapeutic applications for epilepsy and obesity, BIOORG MED, 10(9), 2000, pp. 919-921

Authors: Slassi, A Edwards, L O'Brien, A Meng, CQ Xin, T Seto, C Lee, DKH MacLean, N Hynd, D Chen, C Wang, H Kamboj, R Rakhit, S

Citation: A. Slassi et al., 5-alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists, BIOORG MED, 10(15), 2000, pp. 1707-1709

Authors: Slassi, A Meng, CQ Dyne, K Wang, X Lee, DKH Kamboj, R McCallum, KL Mazzacco, L Rakhit, S

Citation: A. Slassi et al., Conformationally constrained 5-(thienyl)tryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine, MED CHEM RE, 9(9), 1999, pp. 668-674

Authors: Owolabi, JB Rizkalla, G Tehim, A Ross, GM Riopelle, RJ Kamboj, R Ossipov, M Bian, D Wegert, S Porreca, F Lee, DKH

Citation: Jb. Owolabi et al., Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat, J PHARM EXP, 289(3), 1999, pp. 1271-1276